欧盟 - 捷克文 - EMA (European Medicines Agency)

merck sharp & dohme b.v. - doravirine - hiv infekce - antivirotika pro systémové použití - pifeltro is indicated, in combination with other antiretroviral medicinal products, for the treatment of adults, and adolescents aged 12 years and older weighing at least 35 kg infected with hiv 1 without past or present evidence of resistance to the nnrti class.

欧盟 - 捷克文 - EMA (European Medicines Agency)

pfizer europe ma eeig - talazoparib - neoplasmy prsů - antineoplastická činidla - talzenna je indikován jako monoterapie k léčbě dospělých pacientů s germline brca1/2 mutace, kteří mají her2-negativní lokálně pokročilým nebo metastazujícím karcinomem prsu. patients should have been previously treated with an anthracycline and/or a taxane in the (neo)adjuvant, locally advanced or metastatic setting unless patients were not suitable for these treatments. pacienti s hormonální receptory (hr)-pozitivní rakoviny prsu by bylo zacházeno s předchozí endokrinní terapie na bázi, nebo být považovány za nevhodné pro endokrinní terapie na bázi.

欧盟 - 捷克文 - EMA (European Medicines Agency)

seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - antineoplastická činidla - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.

欧盟 - 捷克文 - EMA (European Medicines Agency)

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastická činidla - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.

欧盟 - 捷克文 - EMA (European Medicines Agency)

siga technologies netherlands b.v. - tecovirimat - poxviridae infections; cowpox; monkeypox; vaccinia; smallpox - antivirotika pro systémové použití - tecovirimat siga is indicated for the treatment of the following viral infections in adults and children with body weight at least 13 kg:- smallpox- monkeypox- cowpoxtecovirimat siga is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13 kg (see sections 4. 4 a 5. tecovirimat siga should be used in accordance with official recommendations.

捷克共和国 - 捷克文 - SUKL (Státní ústav pro kontrolu léčiv)

medochemie bohemia, spol. s r.o., praha array - 16464 vÁpenatÁ sŮl atorvastatinu - potahovaná tableta - 10mg - atorvastatin

捷克共和国 - 捷克文 - SUKL (Státní ústav pro kontrolu léčiv)

medochemie bohemia, spol. s r.o., praha array - 16464 vÁpenatÁ sŮl atorvastatinu - potahovaná tableta - 20mg - atorvastatin

捷克共和国 - 捷克文 - SUKL (Státní ústav pro kontrolu léčiv)

medochemie bohemia, spol. s r.o., praha array - 16464 vÁpenatÁ sŮl atorvastatinu - potahovaná tableta - 40mg - atorvastatin

捷克共和国 - 捷克文 - SUKL (Státní ústav pro kontrolu léčiv)

gedeon richter plc., budapešť array - 18800 atorvastatin-lysin; 12990 amlodipin-besilÁt - potahovaná tableta - 10mg/10mg - atorvastatin a amlodipin

捷克共和国 - 捷克文 - SUKL (Státní ústav pro kontrolu léčiv)

gedeon richter plc., budapešť array - 18800 atorvastatin-lysin; 12990 amlodipin-besilÁt - potahovaná tableta - 10mg/5mg - atorvastatin a amlodipin